Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with psychoanalytic post-termination meetings

J Schachter, G C Martin, M J Gundle

    The International Journal of Psycho-Analysis
    |March 26, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same journal

    Letter from Oslo.

    The International journal of psycho-analysis·2026
    Same journal

    Marion Milner's foundational influence on Bion's conception of reverie and Winnicott's conception of play.

    The International journal of psycho-analysis·2026
    Same journal

    How to train psychoanalysts in our time? Exploring controversies around teleanalysis.

    The International journal of psycho-analysis·2026
    Same journal

    Gaza: another psychoanalytic perspective. Reflection on the work of Shmuel Erlich.

    The International journal of psycho-analysis·2026
    Same journal

    Introduction: Questions about internal, external and shared frames, types of loss, methods for scientific dialogue, and the sources of power and authority.

    The International journal of psycho-analysis·2026
    Same journal

    Freud, Sebald and the head of Medusa: The unconscious sense of guilt.

    The International journal of psycho-analysis·2026
    See all related articles

    Post-termination meetings between analysts and patients can be beneficial, aiding further growth and solidifying analytic gains. This challenges the assumption that all post-treatment contact is harmful.

    Area of Science:

    • Psychology
    • Psychoanalysis

    Background:

    • The traditional view in psychoanalysis often discourages post-termination contact between analyst and patient, assuming it is detrimental unless part of further treatment.
    • This study examines the controversial issue of the appropriate relationship and interaction between analyst and patient after the formal termination of therapy.

    Observation:

    • Three case studies involving post-termination meetings were analyzed to understand their impact on patients.
    • Observations focused on how these meetings influenced the patient's therapeutic process and outcomes post-termination.

    Findings:

    • Post-termination meetings facilitated re-engagement in treatment for one patient, leading to significant growth.
    • In other cases, these meetings helped patients process mourning for the analyst and achieve further analytic gains.

    Related Experiment Videos

  • The overall impression was that post-termination contacts were helpful, contradicting the assumption that such contact is inherently harmful.

    • Implications:

    • Post-termination meetings may stabilize analytic gains and provide a valuable later perspective on the therapeutic outcome.
    • These meetings offer opportunities for further analytic work and a more inclusive evaluation of the entire analysis.
    • The findings encourage exploration and reporting of such meetings to build clinical data and challenge existing assumptions.